Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma

Fumihiko Hirai, Takashi Seto, Takeharu Yamanaka, Ryo Toyozawa, Eiko Inamasu, Miyako Kojo, Gouji Toyokawa, Yosuke Morodomi, Yoshimasa Shiraishi, Tomoyoshi Takenaka, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Yukito Ichinose

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences